We are live on
!
Find out more
FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.45%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$179M
AUM Growth
-$7.75M
(-4.1%)
Cap. Flow
-$5.81M
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
36.27%
Holding
157
New
8
Increased
25
Reduced
68
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.39M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$791K |
| 3 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$786K |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$693K |
| 5 |
DERM
Dermira, Inc.
DERM
|
+$597K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.26M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$669K |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
+$616K |
| 4 |
Ubiquiti
UI
|
+$493K |
| 5 |
Caterpillar
CAT
|
+$426K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.01% |
| 2 | Energy | 7.37% |
| 3 | Consumer Staples | 6.07% |
| 4 | Financials | 5.67% |
| 5 | Consumer Discretionary | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.2M | 9.58% |
355,509
-3,585
| -1% | -$200K |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $13.6M | 7.61% |
279,673
+15,219
| +6% | +$791K |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.47M | 4.17% |
228,873
+296
| +0.1% | +$13K |
|
4
iShares Core S&P 500 ETF
IVV
$898B
| $5.42M | 3.02% |
20,411
-1,259
| -6% | -$346K |
|
5
Altria Group
MO
$113B
| $4.42M | 2.47% |
70,994
+1,050
| +2% | +$69.5K |
|
6
Meta Platforms (Facebook)
META
$1.48T
| $3.81M | 2.13% |
23,852
-361
| -1% | -$64.8K |
|
7
Gilead Sciences
GILD
$163B
| $3.52M | 1.96% |
46,643
-2,600
| -5% | -$207K |
|
8
iShares US Consumer Staples ETF
IYK
$1.41B
| $3.4M | 1.9% |
85,785
-2,985
| -3% | -$123K |
|
9
iShares Select Dividend ETF
DVY
$23.7B
| $3.26M | 1.82% |
34,309
+3,349
| +11% | +$327K |
|
10
CVS Health
CVS
$133B
| $2.88M | 1.61% |
46,373
-500
| -1% | -$35.9K |
|
11
iShares Russell 2000 ETF
IWM
$82.9B
| $2.86M | 1.59% |
18,814
-477
| -2% | -$73.7K |
|
12
Philip Morris
PM
$288B
| $2.73M | 1.52% |
27,416
-667
| -2% | -$69.5K |
|
13
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $2.57M | 1.43% |
68,540
+365
| +0.5% | +$14K |
|
14
Biogen
BIIB
$30.5B
| $2.51M | 1.4% |
9,175
-500
| -5% | -$155K |
|
15
Visa
V
$688B
| $2.46M | 1.37% |
20,567
-2,695
| -12% | -$327K |
|
16
Union Pacific
UNP
$175B
| $2.43M | 1.35% |
18,060
| – | – |
|
17
iShares Russell 1000 ETF
IWB
$49.8B
| $2.4M | 1.34% |
16,344
-185
| -1% | -$28.1K |
|
18
Johnson & Johnson
JNJ
$610B
| $2.35M | 1.31% |
18,348
-1,275
| -6% | -$172K |
|
19
Iron Mountain
IRM
$37.4B
| $2.22M | 1.24% |
67,604
-5,104
| -7% | -$172K |
|
20
Golar LNG
GLNG
$5.02B
| $2.2M | 1.23% |
80,250
| – | – |
|
21
Agios Pharmaceuticals
AGIO
$1.86B
| $2.06M | 1.15% |
25,150
-2,400
| -9% | -$186K |
|
|
IMGN
22
DELISTED
Immunogen Inc
IMGN
| $2.04M | 1.14% |
193,500
-31,000
| -14% | -$306K |
|
23
iShares MSCI EAFE ETF
EFA
$79.2B
| $1.93M | 1.08% |
27,683
-657
| -2% | -$46.8K |
|
24
Phillips 66
PSX
$82.7B
| $1.91M | 1.07% |
19,951
-100
| -0.5% | -$9.73K |
|
25
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $1.91M | 1.07% |
85,110
-8,490
| -9% | -$197K |
|
Similar funds
CIM
CSWM
WWP
GWM
FWM
MWS
AP
AA
Fernwood Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, Fernwood Investment Management held 157 positions worth $179M, down 4.1% from $187M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Fernwood Investment Management withdrew a net $5.81M in Q1 2018, closing 12 positions and reducing 68 holdings. Its most notable exit was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $669K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Energy and Consumer Staples.
Against the trend, Fernwood Investment Management opened a new position in Pfizer worth $1.36M.
- Fernwood Investment Management's largest Q1 2018 buy was Pfizer: 40,429 shares worth $1.36M.
- Fernwood Investment Management added most to MyoKardia, Inc. Common Stock in Q1 2018, an estimated $791K increase.
- Fernwood Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $1.26M.
- Fernwood Investment Management fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q1 2018, selling an estimated $669K.
- Fernwood Investment Management's ten largest holdings make up 36% of its $179M portfolio in Q1 2018.
- Fernwood Investment Management opened 8 new positions and closed 12 in Q1 2018.
- Fernwood Investment Management's portfolio value fell 4.1% quarter-over-quarter to $179M.
Based on Fernwood Investment Management's 13F filing for Q1 2018, filed 3 May 2018.